78.6%
chronic hepatitis delta virus (HDV)cirrhosisbulevirtideBulevirtideDiscussionpegylated interferonHepcludex
… authorisation in June 2023 as the first approved treatment for chronic hepatitis delta virus (HDV) infection in those with significant fibrosis who are non-respon…